transplant rejection Natera Q1 Revenues Grow 62 Percent The company reported $152.3 million in total revenues for the quarter and said the number of tests it processed rose 48 percent from the prior-year quarter. CareDx Q1 Revenues up 76 Percent The company reported $67.4 million in total revenues for the quarter and said testing service revenues rose 89 percent year over year. NY State Department of Health Approves Eurofins Viracor Transplant Rejection Tests The Viracor TRAC donor-derived cell-free DNA test and TruGraf blood gene expression test both assess rejection status in kidney transplant recipients. NephroSant Readies Launch of Kidney Transplant Rejection Assay Premium Following the launch of its urine-based Qsant assay later this year, the firm plans to develop updated versions of it with new biomarkers for different disease indications. CareDx Acquires European Transplant Surveillance Software Firm BFS Molecular The company uses next-generation sequencing data to track the health of transplanted organs and stem cells over time. Mar 16, 2021 NephroSant Raises $16M in Series A Funding Round Feb 26, 2021 GenDx HLA Genotyping Products Receives Health Canada IVD Approval Feb 25, 2021 CareDx Expanding Diagnostic Tech Into Cell Transplant Monitoring Premium Feb 24, 2021 CareDx Q4 Revenues Up 64 Percent Feb 8, 2021 Eurofins Viracor, Cleveland Clinic Sign License Deal for Kidney Transplant Rejection Biomarker Test Feb 2, 2021 Devyser Diagnostics Raises $15.4M Through Private Placement Jan 27, 2021 Devyser Eyes Early Detection of Transplant Rejection With DNA Sequencing Tests Premium Jan 27, 2021 Heart Transplant Cell-Free DNA Test Enables Earlier Detection of Acute Rejection Than Biopsy Premium Jan 19, 2021 Devyser Receives €750K Grant to Build Sequencing Assay for Early Detection of Transplant Rejection Jan 13, 2021 At JPM, Natera CEO Lays Out Growth Potential for NIPT, Transplant, Cancer Testing Jan 7, 2021 CareDx, IDbyDNA Partner to Develop Infectious Disease Dx for Transplant Patients Nov 19, 2020 CGS Administrators Aligns Medicare Coverage for CareDx AlloSure Tests Oct 29, 2020 CareDx Q3 Revenues Up 58 Percent Oct 7, 2020 CareDx Preliminary Q3 Revenues Up 57 Percent Oct 1, 2020 CareDx Shares Spike as AlloSure Heart Transplant Test Garners Final LCD From Palmetto Sep 17, 2020 SVB Leerink Initiates Coverage of Natera With Outperform Rating Aug 5, 2020 NeuMoDx Molecular Receives CE Mark for Quantitative BK Viral Assay Aug 4, 2020 CareDx Q2 Revenues Up 33 Percent Jun 26, 2020 BTIG Initiates Coverage of CareDx With Buy Rating May 15, 2020 CareDx Hybrid Capture Tech for HLA Testing Receives CE Marking Load More Breaking News Enzo Biochem, CLX Health Partner to Support COVID-19 Testing for International Travel Type 1 Diabetes GWAS, Fine-Mapping Leads to New Genetic Loci, Potential Drug Targets LSU Health Sciences Center Wins $2.4M to Lead SARS-CoV-2 Variant Sequencing Program NanoString Technologies, Parker Institute for Cancer Immunotherapy Partner on Cell Therapy Project BGI Americas Collaborating With Champions Oncology on Proteomic Cancer Research Personal Genome Diagnostics Inks Cancer Genomic Profiling Deal with Duke University Health System The Scan Missed Early Cases A retrospective analysis of blood samples suggests early SARS-CoV-2 infections may have been missed in the US, the New York Times reports. Limited Journal Editor Diversity A survey finds low diversity among scientific and medical journal editors, according to The Scientist. How Much of a Threat? Science writes that need for a provision aimed at shoring up genomic data security within a new US bill is being questioned. PNAS Papers on Historic Helicobacter Spread, Brain Development, C. difficile RNAs In PNAS this week: Helicobacter genetic diversity gives insight into human migrations, gene expression patterns of brain development, and more.